Feature | Women's Health | July 08, 2015

Study Suggests Benefits of Mammography Alone Overestimated

Countries that started widescale screening programs earlier found to have similar breast cancer mortality rates to those that started later

mammography, benefits overestimated, Royal Society of Medicine, breast cancer

July 8, 2015 - An in-depth review of randomized trials on screening for various cancers, published in the Journal of the Royal Society of Medicine, shows that the benefits of mammographic screening are likely to have been overestimated. This overestimation results from the use of an unconventional statistical method which differs from that used for other cancer screening trials, concludes the paper co-authored by researchers at King's College London and the University of Strathclyde Institute of Global Public Health at iPRI, France.

The review examined screening methods for breast, colorectal, cervical, prostate and lung cancers.

Started in the 1960s and 70s, the Swedish randomized trials suggested that mammography screening could reduce breast cancer mortality by 20-25 percent in populations where screening is widespread. These findings were, and remain, extremely influential in decisions taken to establish population breast cancer screening programs using mammography.

The goal of cancer screening is principally to reduce the mortality from the disease in question by enabling cancers to be found at an early stage. Early detection reduces the risk of being diagnosed with an advanced cancer that is often deadly. In 2002, the World Health Organization (WHO) recommended that when population screening for breast cancer was implemented in any region, the rate of advanced breast cancers should be monitored: If the program is successful, these rates should show a fall over time, indicating that mammography screening is contributing effectively to reducing breast cancer mortality. Moreover, with increased screening, more rapid and more pronounced falls in breast cancer mortality would be expected in countries that implemented mammography screening programs at the end of the 1980s than in countries that implemented programs ten to fifteen years later.

"Contrary to expectations, numerous studies in North America, Europe and Australia have shown that the rates of advanced breast cancer have not declined in countries where most women regularly attend mammography screening" observed Prof. Philippe Autier, lead author from University of Strathclyde Institute of Global Public Health at iPRI. He went on to note that "other studies have shown that declines in breast cancer mortality were the same in countries that implemented mammography screening end of the 1980s as those that did so ten to twenty years later. The absence of differences in mortality reductions could not be explained by differences in access to modern therapies."

Prof. Richard Sullivan, from the Institute of Cancer Policy, King's College London, observed that "these findings were in sharp contrast with screening for cervical and colorectal cancers, two cancers for which studies have clearly shown the capacity of screening to reduce the numbers of advanced cancers in populations. This has major implications for policy-makers in middle income countries who are now making decisions about where to prioritize cancer screening efforts."

These discrepancies led Autier and his colleagues to undertake an in-depth review of all randomized trials of cancer screening. He concluded that "if the Swedish trials had used similar statistical analyses to other cancer screening trials, reductions in the risk of breast cancer death associated with mammography screening would have been much smaller, probably less than 10 percent."

"The reduction seen in the mortality from breast cancer in many countries is one of the major contributions to cancer control in recent times" noted Peter Boyle, professor and director of the University of Strathclyde Institute of Global Public Health at iPRI. "Many factors have contributed to this success, including earlier presentation and better diagnosis, as well as major improvements in the organization of care (multidisciplinary teams) to specific improvements in surgery, radiotherapy and chemotherapy/endocrine therapy. Currently, assessment of the impact of mammographic screening programs cannot be made without taking advances in breast cancer treatment into account."

For more information: www.jrs.sagepub.com

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Mobile App Data Collection Shows Promise for Population Health Surveys
News | Population Health | January 10, 2019
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the Qure.ai tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...